8-K 1 d8k.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 16, 2006

MYRIAD GENETICS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   0-26642   87-0494517

(State or other

jurisdiction of

incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

320 Wakara Way

Salt Lake City, Utah 84108

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (801) 584-3600

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


 

Page 1 of 4 pages


ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

(e) On November 16, 2006, the stockholders of Myriad Genetics, Inc. (the “Company”) approved at the Company’s 2006 Annual Meeting of Stockholders (i) an amendment to the Company’s 2003 Employee, Director and Consultant Stock Option Plan, as previously amended (the “Option Plan”), to increase the number of shares of common stock available for issuance thereunder by 1,500,000 shares; and (ii) an amendment to the Company’s Employee Stock Purchase Plan, as previously amended (the “ESPP”), to increase the number of shares of common stock available for issuance thereunder by 400,000 shares. The Option Plan and ESPP, each as amended, are attached hereto as exhibits to this Current Report on Form 8-K and are being filed pursuant to this Item 5.02 as Exhibit 99.1 and Exhibit 99.2 to this Current Report on Form 8-K.

 

ITEM 9.01 Financial Statements and Exhibits.

(d) The following exhibits are filed with this report:

 

Exhibit
Number
  

Description

99.1    Myriad Genetics, Inc. 2003 Employee, Director and Consultant Stock Option Plan, as amended.
99.2    Myriad Genetics, Inc. Employee Stock Purchase Plan, as amended.

 

Page 2 of 4 pages


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    MYRIAD GENETICS, INC.

Date: November 17, 2006

   

By:

 

/s/ Peter D. Meldrum

       

Peter D. Meldrum

       

President and Chief Executive Officer

 

Page 3 of 4 pages


EXHIBIT INDEX

 

Exhibit
Number
  

Description

99.1    Myriad Genetics, Inc. 2003 Employee, Directors and Consultant Stock Option Plan, as amended.
99.2    Myriad Genetics, Inc. Employee Stock Purchase Plan, as amended.

 

Page 4 of 4 pages